Alexey A. Tappakhov

Alexey A. Tappakhov

Auto-generated profile, based on publicly available information

Alexey A. Tappakhov

M. K. Ammosov North-Eastern Federal University

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 July 2021 in Biomedicines
Verified
Journal Article
Open access
PDF file
EVElena Vaiman
Elena Vaiman
Natalia A. ShnayderNatalia A. Shnayder
Natalia A. Shnayder
MNMaxim Novitsky
Maxim Novitsky
VDVera S. Dobrodeeva
Vera S. Dobrodeeva
PGPolina S. Goncharova
Polina S. Goncharova
RNRegina F. Nasyrova
Regina F. Nasyrova
(1) Introduction: Extrapyramidal disorders form the so-called extrapyramidal syndrome (EPS), which is characterized by the occurrence of motor disorders as a result of damage to the basal ganglia and the subcortical-thalamic connections. Often, this syndrome develops while taking medications, in particular antipsychotics (APs). (2) Purpose: To review studies of candidate genes encoding dopamine receptors as genetic predictors of development of AP-induced parkinsonism (AIP) and AP-induced tardive dyskinesia (AITD) in patients with schizophrenia. (3) Materials and Methods: A search was carried out for publications of PubMed, Web of Science, Springer, and e-Library databases by keywords and their combinations over the last 10 years. In addition, the review includes earlier publications of historical interest. Despite extensive searches of these commonly used databases and search terms, it cannot be ruled out that some publications were possibly missed. (4) Results: The review considers candidate genes encoding dopamine receptors involved in pharmacodynamics, including genes DRD1, DRD2, DRD3, and DRD4. We analyzed 18 genome-wide studies examining 37 genetic variations, including single nucleotide variants (SNVs)/polymorphisms of four candidate genes involved in the development of AIP and AITD in patients with schizophrenia. Among such a set of obtained results, only 14 positive associations were revealed: rs1799732 (141CIns/Del), rs1800497 (C/T), rs6275 (C/T), rs6275 (C/T) DRD2; rs167771 (G/A) DRD3 with AIP and rs4532 (A/G) DRD1, rs6277 (C/T), rs6275 (C/T), rs1800497 (C/T), rs1079597 (A/G), rs1799732 (141CIns/Del), rs1045280 (C/G) DRD2, rs6280 (C/T), rs905568 (C/G) DRD3 with AITD. However, at present, it should be recognized that there is no final or unique decision on the leading role of any particular SNVs/polymorphisms in the development of AIP and AITD. (5) Conclusion: Disclosure of genetic predictors of the development of AIP and AITD, as the most common neurological adverse drug reactions (ADRs) in the treatment of patients with psychiatric disorders, may provide a key to the development of a strategy for personalized prevention and treatment of the considered complication of AP therapy for schizophrenia in real clinical practice.

21 February 2020 in Neurology, Neuropsychiatry, Psychosomatics
Verified
Journal Article
Open access
PDF file
ATA. A. Tappakhov
A. A. Tappakhov
TPT. E. Popova
T. E. Popova
TGT. G. Govorova
T. G. Govorova
Natalia A. ShnayderNatalia A. Shnayder
Natalia A. Shnayder
MSM. R. Sapronova
M. R. Sapronova
Pharmacogenetics of drug-induced dyskinesias in Parkinson's disease

10 January 2020 in Neuromuscular Diseases
Verified
Journal Article
Open access
TGT. G. Govorova
T. G. Govorova
TPTatiana E. Popova
Tatiana E. Popova
ATA. A. Tappakhov
A. A. Tappakhov
Tremor is the most common type of movement disorders. In practice this differential diagnosis of hyperkinesis is diagnosed clinically and the use of additional methods of objective assessment of tremor increases the accuracy of diagnosis. The use of paraclinical methods of objective assessment of tremor improves the accuracy of diagnosis. Comparison of the neurophysiological parameters of tremor with clinical characteristics has a high diagnostic value, which justifies its use in the routine practice of neurologists. The purpose of the review is to analysis basic electrophysiological characteristics of pathological tremor, as well as the presentation of the material of its own observation.

1 January 2017 in Neurology, Neuropsychiatry, Psychosomatics
Verified
Journal Article
Open access
PDF file
ATA. A. Tappakhov
A. A. Tappakhov
TPT. E. Popova
T. E. Popova
TNT. Ya. Nikolaeva
T. Ya. Nikolaeva
NSN. A. Schnaider
N. A. Schnaider
MPM. M. Petrova
M. M. Petrova
Клиническая картина болезни Паркинсона (БП) включает широкий спектр немоторных симптомов (НМС), которые значительно ухудшают качество жизни пациентов. Эти симптомы плохо диагностируются, поскольку сами пациенты и их родственники не придают им значения. Низкая выявляемость НМС может объясняться недостаточной осведомленностью специалистов о широком спектре симптомов БП, а также дефицитом времени на консультативном приеме. Цель исследования – оценить эффективность использования скрининговой шкалы для своевременного выявления НМС БП. Пациенты и методы. Обследовано две группы пациентов: 1-ю (основную) группу составили 95 пациентов с БП в возрасте от 47 до 83 лет (средний возраст – 64,91±7,66 года), 2-ю (контрольную) группу – 37 лиц в возрасте от 48 до 77 лет (средний возраст – 62,22±6,58 года) без признаков БП и паркинсонизма другой этиологии, сопоставимые с пациентами основной группы по полу и возрасту. Все участники исследования заполняли шкалу для выявления НМС (NMSQuest). Результаты. Среднее число НМС на 1 пациента с БП составило 9,13±4,81 против 5,43±3,4 у лиц контрольной группы (p<0,001). Такие симптомы, как гиперсаливация, гипосмия, дисфагия, тошнота, рвота, запор, повышенная потливость, снижение мотивации и чувство грусти, при БП встречались статистически значимо чаще. Не получено достоверных различий между количеством НМС и формой болезни, а также убедительных данных об их связи с возрастом, стадией заболевания и суммарной эквивалентной дозой принимаемых противопаркинсонических препаратов (в пересчете на леводопу). Заключение. Использование шкал-опросников у пациентов с БП позволяет своевременно выявить большинство НМС. Учитывая ограниченное время на консультирование пациента, особенно на амбулаторном этапе, рекомендуем их заполнение во время ожидания приема врача.

1 January 2022 in Transbaikalian Medical Bulletin
Verified
Journal Article
Closed access
LKL.I. Kopylova
L.I. Kopylova
TNT. Ya. Nicolaeva
T. Ya. Nicolaeva
ATA. A. Tappakhov
A. A. Tappakhov
TPTatiana E. Popova
Tatiana E. Popova

12 November 2021 in Russian neurological Journal
Verified
Journal Article
Closed access
PDF file
ATA. A. Tappakhov
A. A. Tappakhov
TNT. Ya. Nikolaeva
T. Ya. Nikolaeva
TPTatiana E. Popova
Tatiana E. Popova
Natalia A. ShnayderNatalia A. Shnayder
Natalia A. Shnayder
Alzheimer’s disease (AD) is the most common cause of dementia in the population. Late onset AD has a classic clinical picture with short-term memory deficit, apraxia and agnosia. Patients with early-onset AD may have an atypical clinical picture which complicates diagnosis. Atypical AD variants include the logopenic variant of primary progressive aphasia, posterior cortical atrophy, behavioral, biparietal, and cortico-basal variants. These variants have pathomorphological signs similar to classical AD, but at an early stage they are characterized by focal atrophy which explains their clinical polymorphism. This article provides a review of the current literature on atypical types of AD and presents a clinical case of a 62-year-old patient in whom the disease debuted with prosopagnosia due to focal atrophy of the temporo-occipital regions of the non-dominant hemisphere.